Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-11

Clinical Trial Update: Safety for 24 Weeks Intake of Korean Red Ginseng in Adults [NA]

View source ↗

Summary

This update reports safety findings from a 24-week intake of Korean Red Ginseng in adults, including healthy individuals and those with diabetes, hypertension, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Korean Red Ginseng (Panax ginseng)

Snippet

Sponsor: Korea Ginseng Corporation | Conditions: Healthy, Diabetes | NA | Status: COMPLETED